Word

RHUDEX

Status

Dead

Status Code

710

Status Date

Friday, September 28, 2012

Serial Number

78285532

Registration Number

2943640

Registration Date

Tuesday, April 26, 2005

Mark Type

1000

Filing Date

Monday, August 11, 2003

Published for Opposition

Tuesday, February 1, 2005

Cancellation Date

Friday, September 28, 2012

Trademark Owner History

MEDIGENE LIMITED -
Avidex Limited - Original Registrant

Classifications

5 Antibodies, proteins, T cell proteins and peptides for medical use, monoclonal antibodies for clinical or medical use, pharmaceutical and biochemical substances and preparations, namely, small molecules, CD8O antagonists for the treatment of cancer, rheumatoid arthritis and auto-immune diseases; in vivo immunotherapeutic, immunoprophylactic and immunodiagnostic agents, preparations and substances for clinical or medical use; vaccines; protein conjugates; diagnostic and analytical preparations for medical and veterinary use, namely, products to diagnose and analyze tissue damage caused by inflammation due to auto-immune diseases; enzymes and enzyme preparations for clinical or medical use and the treatment of cancer, rheumatoid arthritis and auto-immune diseases; chemical products for use in medical science, namely, T-cell receptors, small molecule and protein therapeutics

10 Apparatus and instruments for diagnostic and therapeutic research, namely, instruments for measuring tissue damage or movement in limbs or organs; display apparatus, namely, multi-well plates and arrays for medical or clinical diagnosis and analysis; surgical and medical apparatus and instruments, namely, injectors, syringes, pre-filled vials containing pharmaceuticals and bioceuticals, namely small molecules and protein therapeutics involving T-cell receptors for the treatment of cancer, rheumatoid arthritis and auto-immune diseases

42 Biotechnology services, namely, the development of T-cell receptor pharmaceutical products and technologies for the treatment of cancer, rheumatoid arthritis, inflammatory and auto-immune diseases; scientific and medical research and development of new technology for others in the field of biotechnology and genomics, pharmaceutical drug development services, and pharmaceutical product development; genetic engineering services, licensing intellectual property namely, trademarks and patents in the field of biotechnology

Trademark Events

Sep 28, 2012

Cancelled Sec. 8 (6-Yr)

Dec 17, 2008

Teas Change Of Correspondence Received

Dec 17, 2008

Teas Change Of Correspondence Received

Sep 19, 2007

Automatic Update Of Assignment Of Ownership

Apr 26, 2005

Registered-Principal Register

Feb 1, 2005

Published For Opposition

Jan 12, 2005

Notice Of Publication

Nov 30, 2004

Law Office Publication Review Completed

Nov 29, 2004

Assigned To Lie

Nov 21, 2004

Approved For Pub - Principal Register

Aug 30, 2004

Amendment From Applicant Entered

Aug 5, 2004

Correspondence Received In Law Office

Aug 5, 2004

Sec. 1(B) Claim Deleted

Aug 5, 2004

Paper Received

Feb 3, 2004

Non-Final Action Mailed

Jan 24, 2004

Assigned To Examiner